Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        Altera
        Empower
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        Renasight
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Order Forms
        
        Signatera
        Signatera Publications
        Altera
        Empower
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        Prospera
        Renasight
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        Horizon
        Panorama
        Empower
        Vistara
        Anora
        Spectrum
        Natera Academy Provider Education Hub
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Prospera
Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection

Previous Resource

Why Prospera Series - For Cause: Avoid Complicated Biopsy Brochure
Next Article

Results from the Trifecta Study: Combining Fraction and Estimated Amount of dd-cfDNA to Assess Kidney Transplant Rejection

Related content

5 days ago
Prospera Heart Pediatric Brochure

Read More
16 days ago
Dr Bunnapradist discusses his authorship in the ProActive Study and unmet need in seemingly stable populations / subclinical rejection

Watch Video
27 days ago
Prospera Heart Peds MD Brochure

Read More
about 1 month ago
What is the difference between this test and our regular or routine labs

Watch Video
about 1 month ago
Why does monitoring matter

Watch Video
about 1 month ago
What is the process to use Natera's Prospera test

Watch Video
about 1 month ago
Two thresholds, one powerful solution: Combining the quantity and fraction of dd-cfDNA in a single blood test to improve the accuracy of non

Learn how the addition of DQS significantly reduces the rate of false positive results and improves the accuracy of detecting both acute cellular rejection (ACR) and antibody mediated rejection (AMR).

Watch Video
about 1 month ago
Dr. Rao DQS case studies

Watch Video
about 1 month ago
Dr. Lampert DQS case studies

Watch Video
about 1 month ago
Brian's Story: Surveilling with Prospera caught rejection early and saved his kidney

Watch Video
about 1 month ago
Prospera Patient Portal Guide SPANISH

Read More
about 1 month ago
Prospera Kidney- Patient Brochure- SPANISH

Read More
about 1 month ago
Prospera Kidney- Billing Guide SPANISH

Read More
about 1 month ago
Video para Pacientes de Prospera

Watch Video
about 2 months ago
ASN Kidney Week 2024

Read More
about 2 months ago
How to Engage Your Kidney Transplant Recipients

Being Proactive with Prospera on Their Transplant Care

Watch Video
about 2 months ago
How Dr. Hajjiri established Prospera™ monitoring protocols for low immunological risk, high immunological risk developing Acute kidney - Pod

Listen Now
about 2 months ago
How Dr. Athreya uses a Prospera™ surveillance protocol for his kidney-pancreas recipients - Podcast

Listen Now
about 2 months ago
How Professor Viklicky used Prospera™ to monitor treatment response in both ABMR and TCMR cases - Podcast

Listen Now
about 2 months ago
How Dr. Hajjiri established Prospera™ monitoring protocols for low immunological risk, high immunological risk developing Acute kidney Injur

Watch Video

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.